152 results
Page 3 of 8
424B5
d341gn9
26 Jan 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-1.1
8qjjb1 4fdt5
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
424B5
ukt ql28k
25 Jan 21
Prospectus supplement for primary offering
4:16pm
424B3
9nkizi9deu6r hfrol
4 Dec 20
Prospectus supplement
4:48pm
424B5
yxhafovzk775 vrgrhlm
8 Sep 20
Prospectus supplement for primary offering
4:43pm
424B5
1q73ijf955
12 Mar 20
Prospectus supplement for primary offering
5:27pm
424B4
z5u9rco2g3qt87xun43
11 Feb 20
Prospectus supplement with pricing info
5:14pm
S-8
EX-4.3
j2ssvydc5 u5049n
15 Aug 19
Registration of securities for employees
4:32pm
8-K
EX-10.1
hn4ri6lsxoxr7eq9e
14 Aug 19
Departure of Directors or Certain Officers
4:37pm